V2 Receptor Antagonists in Cystic Kidney Diseases: An Exciting Step Towards a Practical Treatment

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2005020136
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

The Vasopressin V2 Receptor Antagonists: The Vaptans

Global Journal of Endocrinological Metabolism
2018English

Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases

Frontiers in Neuroscience
Neuroscience
2016English

Diseases of the Urinary System. Advances in the Treatment of Kidney Diseases: An Introduction.

BMJ
1977English

Towards Therapy in Genetic Kidney Diseases: Hopes and Uncertainties

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2009English

An Exciting New Era in the Treatment of Myeloproliferative Neoplasms

Oncology & Hematology Review (US)
2016English

Exciting Advancements in Ovarian Cancer Treatment

2019English

Role of Leukotriene Receptor Antagonists in the Treatment of Exercise-Induced Bronchoconstriction: A Review

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2005English

The Cystic Kidney

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1990English

Dermatoglyphics in Kidney Diseases: A Review

SpringerPlus
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy